{
  "timestamp": "2026-01-05T06:41:03.560172",
  "trigger": "after_user_assist",
  "agent_id": "user_assist",
  "context": {
    "user_assist": {
      "summary": "Follow-up session detailing worsening symptoms of Major Depressive Disorder and inadequate clinical response to the initial dose of Sertraline.",
      "clinical_nature": "follow-up",
      "validation_result": "approved",
      "reasoning": "This is a standard follow-up session occurring four weeks post-initiation of an SSRI (Sertraline). The provider is assessing efficacy and safety, particularly noting the patient's reports of significant vegetative symptoms, severe anhedonia, and the presence of passive suicidal ideation, necessitating an acute medication adjustment and safety validation."
    }
  }
}